Chester County News and Community Website
PHILADELPHIA, PA — iECURE said the U.S. Food and Drug Administration has selected ECUR-506, the company’s investigational gene insertion therapy for neonatal-onset ornithine transcarbamylase deficiency, for the agency’s Chemistry, Manufacturing, …
FDA Selects iECURE Therapy for Manufacturing Readiness Pilot Program Read More
WASHINGTON, D.C. — Children with a life-threatening immune disorder now have a new treatment option following federal approval of the first gene therapy designed to correct the underlying cause of …
FDA Approves First Gene Therapy for Rare Childhood Immune Disorder Read More
SPRING HOUSE, PA — Johnson & Johnson (NYSE: JNJ) said the U.S. Food and Drug Administration has approved ICOTYDE (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and …
FDA Approves Johnson & Johnson Psoriasis Drug ICOTYDE Read More
WASHINGTON, D.C. — Children with a rare genetic disorder that affects the brain and body will have access to a newly approved treatment designed to slow disease progression, federal regulators …
FDA Approves First Treatment Targeting Hunter Syndrome Brain Effects Read More
WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) said the U.S. Food and Drug Administration has not identified bioequivalence deficiencies in its abbreviated new drug application for a preservative-free ketamine …
NRx Says FDA Finds No Bioequivalence Issues in Ketamine Filing Read More WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) said it has received written confirmation from the U.S. Food and Drug Administration supporting a path toward approval of its depression treatment …
NRx Says FDA Will Review NRX-100 Without New Trials Read More
WASHINGTON, D.C. — The U.S. Department of Energy is opening a $293 million funding opportunity aimed at accelerating scientific breakthroughs using artificial intelligence across multiple industries, including energy, manufacturing, and …
$293M AI Funding Targets Breakthrough Science Challenges Read More
WASHINGTON, D.C. — Workers who believe they have faced religious discrimination on the job now have a new federal resource to seek guidance, as the U.S. Department of Labor launches …
New Federal Site Targets Religious Bias at Workplaces Read More
WASHINGTON, D.C. — A federally approved land exchange in Arizona will allow development of a major copper mine expected to create jobs and boost domestic mineral production, following a court …
Arizona Land Deal Clears Path for Major Copper Mine Read More
PHILADELPHIA, PA — GSK plc (NYSE: GSK) said the U.S. Food and Drug Administration has expanded approval of its RSV vaccine AREXVY to include adults ages 18 to 49 who …
FDA Expands GSK RSV Vaccine Use to At-Risk Adults Ages 18–49 Read More